Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

331 ARTÍCULOS , VIENDO DEL 226 AL 240

Agitation and aggression in Alzheimer's disease: an update on pharmacological and psychosocial approaches to care

Gallagher D, Herrmann N.

Neurodegener Dis Manag. 2015;5(1):75-83. doi: 10.2217/nmt.14.46.

Demographic and Socioenvironmental Characteristics of Black and White Community-Dwelling Caregivers and Care Recipients' Behavioral and Psychological Symptoms of Dementia

Cothran FA, Farran CJ, Barnes LL, Whall AL, Redman RW, Struble LM, Dunkle RE, Fogg L.

Res Gerontol Nurs. 2015 Jul-Aug;8(4):179-87. doi: 10.3928/19404921-20150310-01. Epub 2015 Mar 10.

[Disclosing the diagnosis and guidance]

Bopp-Kistler I.

Ther Umsch. 2015 Apr;72(4):225-31. doi: 10.1024/0040-5930/a000669.

The selective positive allosteric M1 muscarinic receptor modulator PQCA attenuates learning and memory deficits in the Tg2576 Alzheimer's disease mouse model

Puri V, Wang X, Vardigan JD, Kuduk SD, Uslaner JM.

Behav Brain Res. 2015;287:96-9. doi: 10.1016/j.bbr.2015.03.029. Epub 2015 Mar 20.

The role of dietary coconut for the prevention and treatment of Alzheimer's disease: potential mechanisms of action

Fernando WM, Martins IJ, Goozee KG, Brennan CS, Jayasena V, Martins RN.

Br J Nutr. 2015 Jul 14;114(1):1-14. doi: 10.1017/S0007114515001452. Epub 2015 May 22.

"Fumbling About with Alzheimer's": One Disease, Three Women and a Camera

Capp R.

Gerontologist. 2015 Jun;55(3):497-9. doi: 10.1093/geront/gnv059.

Non-pharmacological interventions for adults with mild cognitive impairment and early stage dementia: An updated scoping review

Rodakowski J, Saghafi E, Butters MA, Skidmore ER.

Mol Aspects Med. 2015 Jun-Oct;43-44:38-53. doi: 10.1016/j.mam.2015.06.003. Epub 2015 Jun 10.

Protection against Brain Atrophy by Anti-dementia Medication in Mild Cognitive Impairment and Alzheimer's Disease: Meta-Analysis of Longitudinal Randomized Placebo-Controlled Trials

Kishi T, Matsunaga S, Oya K, Ikuta T, Iwata N.

Int J Neuropsychopharmacol. 2015 Jun 19;18(12):pyv070. doi: 10.1093/ijnp/pyv070.

Advancements in the treatment of agitation in Alzheimer's disease

Antonsdottir IM, Smith J, Keltz M, Porsteinsson AP.

Expert Opin Pharmacother. 2015;16(11):1649-56. doi: 10.1517/14656566.2015.1059422.

Prevention of sporadic Alzheimer's disease: lessons learned from clinical trials and future directions

Andrieu S, Coley N, Lovestone S, Aisen PS, Vellas B.

Lancet Neurol. 2015 Sep;14(9):926-944. doi: 10.1016/S1474-4422(15)00153-2. Epub 2015 Jul 23.

EFFECT OF EICOSAPENTAENOIC ACID AND DOCOSAHEXAENOIC ACID SUPPLEMENTATIONS TO CONTROL COGNITIVE DECLINE IN DEMENTIA AND ALZHEIMER'S DISEASE: A SYSTEMATIC REVIEW

de Souza Fernandes DP, Canaan Rezende FA, Pereira Rocha G, De Santis Filgueiras M, Silva Moreira PR, Gonçalves Alfenas Rde C.

Nutr Hosp. 2015 Aug 1;32(2):528-33. doi: 10.3305/nh.2015.32.2.9111.

Cannabinoids for the Treatment of Agitation and Aggression in Alzheimer's Disease

Liu CS, Chau SA, Ruthirakuhan M, Lanctôt KL, Herrmann N.

CNS Drugs. 2015 Aug;29(8):615-23. doi: 10.1007/s40263-015-0270-y.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias